Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /CNW/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to ...

Anne Jordan was diagnosed with blood cancer in 2016. After multiple treatments of chemotherapy and radiation, her doctors recommended she consult Dr. Nakhle Saba, director of the CAR-T program at ...

April 13 (Reuters) - Allogene Therapeutics said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of cancer relapse in patients ...

Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...

Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...

Fourteen months after treatment with engineered immune cells, the recipient has no symptoms and doesn’t need to take ...

The CAR-T Cellular Team at Children’s Hospital of The King’s Daughters is making it easier for children — and their families ...